Keratoprotective agent, antioxidant agent. Dry eye syndrome, age-related cataract (to slow the progression of the disease
Latin name:
VISOMITIN
Release form:
eye drops
Owner / Registrar
MITOTEKH, OOO
International Classification of Diseases Other diseases of the lacrimal gland
Pharmacological group:
Preparation for moisturizing and protecting the cornea
pharmachologic effect VISOMITIN:
Plastoquinonyldecyltriphenylphosphomy bromide (PDTP) is a plastoquinone derivative, which is linked to a triphenylphosphine residue via a linker chain (CIO). PDTP at low (nanomolar) concentrations exhibits high antioxidant activity. It also has a stimulating effect on the process of tear production, epithelization, and helps to increase the stability of the tear film.
Pharmacokinetics VISOMITIN:
Pharmacokinetic studies in humans have not been conducted. In preclinical studies on animals, the distribution of PDTP in organs and tissues occurred within 48 hours after intravenous and intragastric administration. It was found that PDTP is present in the highest concentrations in the tissues of the kidney, liver and heart within 1 hour after administration. PDTP relatively quickly undergoes enzymatic degradation and covalent binding to proteins.
Allergic reactions
Overdose:
There are no data on overdose with topical application.
special instructions VISOMITIN:
Influence on the ability to drive vehicles and use mechanisms
If, after using the drug, a short-term blurred vision occurs, it is not recommended to drive vehicles and engage in activities that require increased concentration until it is restored.
Application during pregnancy and lactation VISOMITIN:
There are no adequate controlled studies in pregnant and breastfeeding women. It is not recommended to prescribe the drug during pregnancy. If necessary, the appointment during lactation for the period of treatment, breastfeeding should be discontinued.
Drug interactions VISOMITIN:
If necessary, you can use it simultaneously with other eye drops. In this case, the break between instillations should be at least 5 minutes.
How to take VISOMITIN:
1-2 drops of the drug in t
Storage conditions and shelf life
In a dark place at a temperature of 2-8 ° C. Store the open bottle in a dark place at a temperature of 2-8 ° C; use within 1 month. Keep out of reach of children. Shelf life - 1 year. Do not use after the expiration date printed on the package. Use an opened bottle within 1 month.
